Recursion Pharmaceuticals
ENTRABBNVIDIA partnership + Exscientia merger. Industrialized drug-discovery AI.
recursion.com220 open roles at Recursion Pharmaceuticals
Verified live postings · updated FEB 12, 2026
Get notified when Recursion Pharmaceuticals posts a new role
Free · email when published · no weekly noise
Hiring quality verdict.
Recursion's NVIDIA partnership plus the Exscientia merger anchors industrialized drug-discovery AI at production scale. 220+ AI-tagged roles concentrated in Salt Lake City and Toronto. The thesis is map-the-cell — large-scale phenomic data plus deep-learning models.
Recursion Pharmaceuticals by the numbers.
220
Verified live postings
+48%
Net-new AI hires (12-month)
Public · NASDAQ:RXRX
Biotech AI · Drug Discovery
Verified salary ranges.
Total comp · USD · annual
Who runs talent at Recursion Pharmaceuticals.
Chris Gibson
Co-founder & CEO
Recursion Pharmaceuticals in ENTRA Intelligence.
OxCam Arc: Life Sciences AI Pay Transparency at the Corridor's Edge
AstraZeneca Cambridge posts ML roles at £80K–£130K base, disclosure rate hits 72%, as September's +31% PhD surge restarts the OxCam life sciences AI corridor.
Silicon Slopes Runs on Borrowed Rules
Utah has no pay disclosure statute. Forty-three percent of Silicon Slopes AI postings carry salary bands anyway — because California and Colorado wrote the rules, and they travel.
Top 10 Healthcare AI Employers 2026
Abridge anchors the field at $5.3B. Tempus IPO'd. Recursion + Isomorphic Labs reset drug-discovery comp. NHS England runs ~£600M in sovereign procurement. The 10 healthcare AI employers reshaping the senior-IC AI funnel.
Recursion Pharmaceuticals vs. peers.
More coverage
Browse all companies in our editorial coverage.